Regenxbio Inc (RGNX)

EBITDA

$34.26M

Quarterly · Period ending: · USD

RGNX logo

RGNX EBITDA

Latest reported$34.26M
RGNX Quarterly EBITDA ($821.00K → $34.26M)
High-resolution chart · PNG

RGNX ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regenxbio Inc EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
34,259,000
-77,486,000
-51,004,000
-44,886,000
-55,973,000
18,608,000
-37,746,000
-54,816,000
-48,489,000
-57,177,000
-57,343,000
-55,872,000
-66,506,000
-59,743,000
-51,542,000
-65,981,000
-58,676,000
-68,043,000
316,532,000
-48,868,000
-49,072,000
-41,504,000
-37,622,000
10,964,000
-32,130,000
-38,044,000
-38,401,000
-34,030,000
-35,123,000
-34,292,000
3,761,000
-21,784,000
7,246,000
102,859,000
-15,875,000
-20,603,000
-14,353,000
-22,368,000
-19,763,000
-18,508,000
-14,896,000
-11,203,000
-5,462,000
-7,319,000
-6,281,000
2,000
-18,000
-25,000
0
821,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.